[STOK] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[STOK] Stoke Therapeutics, Inc.
Announcement Date
15-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -8.65%
YoY- -92.25%
Quarter Report
STOK's Result
STOK's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 4,216 5,152 3,000 0 0 0 0 -
PBT -26,374 -22,545 -24,649 -16,793 -11,039 -5,742 -1,912 54.80%
Tax 1,070 -4,248 -250 -254 -674 0 0 -
NP -26,374 -18,297 -24,399 -16,793 -11,039 -5,742 -1,912 54.80%
Tax Rate - - - - - - - -
Total Cost 30,590 23,449 27,399 16,793 11,039 5,742 1,912 58.67%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -625.57 -355.14 -813.30 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.57 -0.43 -0.65 -0.46 -0.34 -0.19 -0.08 38.67%
EPS Diluted -0.57 -0.43 -0.65 -0.46 -0.34 -0.19 -0.08 38.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.